What is Roth Capital’s Forecast for Nuwellis Q1 Earnings?

Nuwellis, Inc. (NASDAQ:NUWEFree Report) – Research analysts at Roth Capital decreased their Q1 2025 earnings per share (EPS) estimates for Nuwellis in a report issued on Tuesday, March 11th. Roth Capital analyst J. Aschoff now forecasts that the company will post earnings of ($0.45) per share for the quarter, down from their prior estimate of ($0.30). The consensus estimate for Nuwellis’ current full-year earnings is ($8.17) per share. Roth Capital also issued estimates for Nuwellis’ Q2 2025 earnings at ($0.36) EPS, Q3 2025 earnings at ($0.35) EPS, Q4 2025 earnings at ($0.28) EPS, FY2025 earnings at ($1.39) EPS, FY2026 earnings at ($0.52) EPS, FY2027 earnings at $0.09 EPS, FY2028 earnings at $0.78 EPS and FY2029 earnings at $1.41 EPS.

Nuwellis Price Performance

Shares of NASDAQ NUWE opened at $1.15 on Thursday. The stock has a market capitalization of $5.03 million, a price-to-earnings ratio of -0.01 and a beta of 0.36. The firm’s 50 day simple moving average is $1.22 and its 200-day simple moving average is $1.34. Nuwellis has a 12 month low of $0.92 and a 12 month high of $16.63.

Institutional Trading of Nuwellis

An institutional investor recently bought a new position in Nuwellis stock. Geode Capital Management LLC bought a new position in shares of Nuwellis, Inc. (NASDAQ:NUWEFree Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 30,806 shares of the company’s stock, valued at approximately $34,000. Geode Capital Management LLC owned approximately 0.70% of Nuwellis as of its most recent SEC filing. Hedge funds and other institutional investors own 3.13% of the company’s stock.

About Nuwellis

(Get Free Report)

Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.

Further Reading

Earnings History and Estimates for Nuwellis (NASDAQ:NUWE)

Receive News & Ratings for Nuwellis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuwellis and related companies with MarketBeat.com's FREE daily email newsletter.